/

Other

/

UCB

UCB

UCB

Verified Nov 2026

Other

·

Anderlecht, Brussels

·

Since 1928

UCB (Union Chimique Belge) is a Brussels-based biopharmaceutical company founded in 1928 that develops medicines for neurology, immunology, and rare diseases. Employing 10,000–50,000 people with annual revenue of €6 billion, the privately held firm invests over 25% of revenue into research and development. In 2026, UCB committed to building a biologics manufacturing campus in Georgia expected to create 330 permanent jobs.

UCB

Verified Nov 2026

AT A GLANCE

Founded

1928

Headquarters

Anderlecht, Brussels

Employees

10,000-50,000

Ownership

UCB at a glance

Revenue

$5-10B

Est. band

Employees

10,000-50,000

Founded

1928

Headquarters

Anderlecht, Brussels

Certifications

ISO 14001

Import activity

10920

Industries

Automotive

Electric Vehicles

Medical

Renewable Energy

Industrial Equipment

Sourcing and import activity

From US customs bill-of-lading records

US sea imports

10920

Named foreign suppliers

50

Top origins

Republic of Korea · China · Singapore · Vietnam

Chart of the supplier's US import shipment volume trend over time

Shared foreign counterparties do not establish that these companies buy from UCB.

What this tells a buyer

UCB processed over 10,900 shipments across supply chains originating primarily from Asia, including South Korea, China, Singapore, Vietnam, Malaysia, Taiwan, India, and Thailand.

The company manufactures medicines for epilepsy, Parkinson's disease, and rheumatoid arthritis, and holds ISO 14001 certification for environmental management.

UCB operates in over 40 countries and acquired Candid Therapeutics in 2026 to expand its immunology pipeline with T-cell engager technologies.

Source: US customs bill-of-lading records and public filings · Last verified Nov 13, 2026

STABILITY SIGNALS

Established & active

98 years in operation (founded 1928).

10,920 US import shipments on record.

Holds ISO 14001 certification(s) per public sources.

Overview

UCB (Union Chimique Belge) is a Brussels-based biopharmaceutical company founded in 1928 that develops medicines for neurology, immunology, and rare diseases. Employing 10,000–50,000 people with annual revenue of €6 billion, the privately held firm invests over 25% of revenue into research and development. In 2026, UCB committed to building a biologics manufacturing campus in Georgia expected to create 330 permanent jobs.

At a glance

Attribute

Detail

Founded

1928

Headquarters

Anderlecht, Brussels

Employees

10,000-50,000

Revenue

$5-10B (estimated)

Certifications

ISO 14001

What UCB makes

The company manufactures medicines for epilepsy, Parkinson's disease, and rheumatoid arthritis, and holds ISO 14001 certification for environmental management.

Certifications

UCB is associated with the following certifications in public sources. Confirm the certified scope for the specific plant producing your part:

Trade and customs footprint

UCB processed over 10,900 shipments across supply chains originating primarily from Asia, including South Korea, China, Singapore, Vietnam, Malaysia, Taiwan, India, and Thailand. US customs bill-of-lading records list 10920 inbound shipments across 50 foreign suppliers, with top origins including Republic of Korea · China · Singapore · Vietnam.

Latest developments

Facilities

UCB is headquartered in Anderlecht, Brussels. Public sources also reference these locations:

Company details

UCB operates in over 40 countries and acquired Candid Therapeutics in 2026 to expand its immunology pipeline with T-cell engager technologies. UCB was founded in 1928, has an estimated 10,000-50,000 employees, and is headquartered in Anderlecht, Brussels. On the LightSource stability read it is rated "Established & active": 98 years in operation (founded 1928). 10,920 US import shipments on record. Holds ISO 14001 certification(s) per public sources.

Frequently asked questions

What does UCB do?

UCB (Union Chimique Belge) is a Brussels-based biopharmaceutical company founded in 1928 that develops medicines for neurology, immunology, and rare diseases. Employing 10,000–50,000 people with annual revenue of €6 billion, the privately held firm invests over 25% of revenue into research and development. In 2026, UCB committed to building a biologics manufacturing campus in Georgia expected to create 330 permanent jobs.

Where is UCB headquartered?

UCB is headquartered in Anderlecht, Brussels.

When was UCB founded?

UCB was founded in 1928.

How big is UCB?

UCB has an estimated 10,000-50,000 employees, with revenue in the $5-10B range (estimated).

What certifications does UCB hold?

UCB lists ISO 14001 on its website. Confirm the certified scope for the specific plant producing your part.

Does UCB import from overseas suppliers?

US customs bill-of-lading records show 10920 inbound shipments for UCB, with top origins including Republic of Korea · China · Singapore · Vietnam.

Related suppliers

Explore other suppliers in the LightSource directory:

Last verified Nov 2026. Is this your company? Request a correction.

Location & contact

Anderlecht, Brussels (HQ)Headquarters · Brussels, Belgium
Anderlecht, Brussels (HQ)Anderlecht, Brussels, BelgiumHeadquarters

Phone

'+32 2 559 99 99

Certification

ISO 14001

Evaluating suppliers like these?

This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.